Match tier
Listed
Presence
Current · Arkansas
Last published
2022
Sources
OpenAlex · ORCID
Refreshed
2026-10-06
Y
Youzhong Yuan
Role not yet determined Is this you? Add your title
Also affiliated: Scripps Research Institute (2001–2003); Harvard University (2001); University of California, Los Angeles (2003); University of Pittsburgh (2004–2013); Second Military Medical University (1999); Chinese Academy of Medical Sciences & Peking Union Medical College (2015); Fudan University (2001); Dana-Farber Cancer Institute (2001); UPMC Hillman Cancer Center (2004–2013); University of Pittsburgh Medical Center (2006); Stanford Medicine (2001); UPMC Montefiore (2006); Institute of Hematology & Blood Diseases Hospital (2015); State Key Laboratory of Genetic Engineering (2001); State Key Laboratory of Experimental Hematology (2015); University of Pennsylvania (2008); Stanford University (2001)
20 h-index
49 pubs
2,455 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Youzhong Yuan's research focuses on the classification and understanding of hematologic malignancies, specifically myelodysplastic syndromes and plasmablastic lymphoma. His work involves analyzing large datasets from multicenter studies to refine diagnostic criteria and characterize disease subtypes. Yuan has published on the reclassification of myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 as acute myeloid leukemia, examining 107 cases. He also contributed to a multi-institutional study and literature review on CD138− plasmablastic lymphoma. Yuan's scholarship metrics include an h-index of 15, with 29 total publications and 952 total citations. His recent activity indicates ongoing engagement in the field of hematopathology.
Metrics
- h-index: 20
- Publications: 49
- Citations: 2,455
Selected Publications
-
CD138− Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature (2022)
-
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases (2021)
-
Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel (2020)
-
The Role of Sirtuin 3 in Radiation-Induced Long-Term Persistent Liver Injury (2020)
-
Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study (2020)
-
Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study (2019)
-
Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment (2019)
-
Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion (2019)
-
The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study (2019)
-
Flower isoforms promote competitive growth in cancer (2019)
-
Identification of a Novel Phenotype of Myeloid Cells in Classical Hodgkin Lymphoma (2018)
-
A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe (2018)
-
Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo (2018)
-
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing (2018)
-
CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall (2018)
Collaboration Network
Top Collaborators
Ginell R. Post
University of Arkansas for Medical Sciences
5 shared publications
In database
- Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies.
- Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing
- Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment
- Identification of a Novel Phenotype of Myeloid Cells in Classical Hodgkin Lymphoma
- Absence of Class A Scavenger Receptor Distinguishes a Phenotype of Tumor Associated Macrophages in Classic Hodgkin's Lymphoma
Steven R. Post
University of Arkansas for Medical Sciences
5 shared publications
In database
- Flower isoforms promote competitive growth in cancer
- Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies.
- Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment
- Identification of a Novel Phenotype of Myeloid Cells in Classical Hodgkin Lymphoma
- Absence of Class A Scavenger Receptor Distinguishes a Phenotype of Tumor Associated Macrophages in Classic Hodgkin's Lymphoma
Alicja Urbaniak
University of Arkansas for Medical Sciences
5 shared publications
In database
- Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo
- Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel
- Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Adam Huczyński
Adam Mickiewicz University in Poznań (PL)
5 shared publications
- Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo
- Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel
- Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Timothy C. Chambers
University of Arkansas for Medical Sciences
5 shared publications
In database
- Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo
- Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel
- Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Yuan Ji
University of Nebraska Medical Center (US)
3 shared publications
- CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall
- Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion
- Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
Magdalena Delgado
University of Arkansas for Medical Sciences (US)
3 shared publications
- Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Fariba Jousheghany
University of Arkansas for Medical Sciences
3 shared publications
In database
- Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Behjatolah Monzavi‐Karbassi
University of Arkansas for Medical Sciences
3 shared publications
In database
- Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Zenggang Pan
Yale University (US)
2 shared publications
- CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall
- CD138− Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature
Mingyi Chen
The University of Texas Southwestern Medical Center (US)
2 shared publications
- CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall
- CD138− Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature
Endi Wang
Duke Medical Center (US)
2 shared publications
- CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall
- Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion
Gang Zheng
Johns Hopkins University (US)
2 shared publications
- CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall
- Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
Thomas Kieber‐Emmons
University of Arkansas for Medical Sciences
2 shared publications
In database
- The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study
- Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: In Vitro and Ex Vivo Study
Wei Wang
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion
- Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
Similar Researchers
Based on overlapping research topics
John Ye
University of Arkansas for Medical Sciences
Medical Case Studies
Retrospective Studies
Disease Mechanisms Research
Ginell Ristic Post
University of Arkansas for Medical Sciences
Medical Case Studies
Lymphoma Diagnosis and Treatment
Disease Mechanisms Research
EK Krause
University of Arkansas for Medical Sciences
Medical Case Studies
Disease Mechanisms Research
Hematopoietic Stem Cell Transplantation
Manojna Konda
University of Arkansas for Medical Sciences
Medical Case Studies
Retrospective Studies
Disease Mechanisms Research
B Poudel
University of Arkansas – Fort Smith
Medical Case Studies
Retrospective Studies
Disease Mechanisms Research
Keerthi Sripathi
Arkansas Colleges of Health Education
Acute Myeloid Leukemia Research
Lymphoma Diagnosis and Treatment
Retrospective Studies